Recent developments in cyclin-dependent kinase biochemical and structural studies.
暂无分享,去创建一个
[1] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[2] S. Blain,et al. Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity , 2007, Molecular and Cellular Biology.
[3] J. LaBaer,et al. New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.
[4] D O Morgan,et al. Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.
[5] Pierre Dubus,et al. Cdk1 is sufficient to drive the mammalian cell cycle , 2007, Nature.
[6] M. Noble,et al. Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design. , 2008, Structure.
[7] S. Elledge,et al. The DNA damage response: putting checkpoints in perspective , 2000, Nature.
[8] J. Slingerland,et al. Phosphorylation of p27Kip1 Regulates Assembly and Activation of Cyclin D1-Cdk4 , 2008, Molecular and Cellular Biology.
[9] G. Shapiro,et al. Cyclin-dependent kinase pathways as targets for cancer treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. P. Fisher,et al. p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes , 2008, Molecular and Cellular Biology.
[11] Ivo Tews,et al. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. , 2002, Biochemistry.
[12] L. Johnson,et al. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. , 2001, Molecular cell.
[13] M. Noble,et al. How Tyrosine 15 Phosphorylation Inhibits the Activity of Cyclin-dependent Kinase 2-Cyclin A* , 2007, Journal of Biological Chemistry.
[14] D. Takeda,et al. Mutational Analysis of the Cy Motif from p21 Reveals Sequence Degeneracy and Specificity for Different Cyclin-Dependent Kinases , 2001, Molecular and Cellular Biology.
[15] L. Johnson,et al. Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product. , 1995, Structure.
[16] D. Morgan,et al. Reciprocal Activation by Cyclin-Dependent Kinases 2 and 7 Is Directed by Substrate Specificity Determinants outside the T Loop , 2001, Molecular and Cellular Biology.
[17] Catherine G. Takizawa,et al. Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. , 2000, Current opinion in cell biology.
[18] N. Pavletich,et al. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. , 2000, Genes & development.
[19] L. Johnson,et al. The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2‐independent roles , 2005, The EMBO journal.
[20] R. Fisher. Secrets of a double agent: CDK7 in cell-cycle control and transcription , 2005, Journal of Cell Science.
[21] L. Johnson,et al. Cyclin B and Cyclin A Confer Different Substrate Recognition Properties on CDK2 , 2007, Cell cycle.
[22] M. Barbacid,et al. Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.
[23] L. Johnson,et al. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.
[24] L. Tsai,et al. Structure and regulation of the CDK5-p25(nck5a) complex. , 2001, Molecular cell.
[25] M. Barbacid,et al. Mammalian cyclin-dependent kinases. , 2005, Trends in biochemical sciences.
[26] Peter M Fischer,et al. Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. , 2008, Trends in pharmacological sciences.
[27] L. Johnson,et al. The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation , 2008, The EMBO journal.
[28] P. Kaldis,et al. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms , 2009, Oncogene.
[29] Martin E M Noble,et al. The Role of the Phospho-CDK2/Cyclin A Recruitment Site in Substrate Recognition* , 2006, Journal of Biological Chemistry.
[30] J. Koča,et al. Different Mechanisms of CDK5 and CDK2 Activation as Revealed by CDK5/p25 and CDK2/Cyclin A Dynamics* , 2006, Journal of Biological Chemistry.
[31] Rajiv Chopra,et al. Crystal structure of human CDK4 in complex with a D-type cyclin , 2009, Proceedings of the National Academy of Sciences.
[32] M. E. M. Noble,et al. The structure of CDK4/cyclin D3 has implications for models of CDK activation , 2009, Proceedings of the National Academy of Sciences.
[33] N. Hayward. Genetics of melanoma predisposition , 2003, Oncogene.
[34] Yan Geng,et al. Cyclin E Ablation in the Mouse , 2003, Cell.
[35] Geoffrey J. Barton,et al. The Jalview Java alignment editor , 2004, Bioinform..
[36] Andrea Musacchio,et al. Mechanism of CDK5/p25 binding by CDK inhibitors. , 2005, Journal of medicinal chemistry.
[37] Shunichi Takeda,et al. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? , 2008, Nature Reviews Molecular Cell Biology.
[38] James M. Roberts,et al. Living with or without cyclins and cyclin-dependent kinases. , 2004, Genes & development.
[39] M. Donzelli,et al. Regulating mammalian checkpoints through Cdc25 inactivation , 2003, EMBO reports.
[40] Zhou Songyang,et al. Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.
[41] L. Johnson,et al. CAK—Cyclin-Dependent Activating Kinase: A Key Kinase in Cell Cycle Control and a Target for Drugs? , 2005, Cell cycle.
[42] J. Sobczak-Thépot,et al. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene , 1997, Nature Genetics.
[43] L. Johnson. Protein kinase inhibitors: contributions from structure to clinical compounds , 2009, Quarterly Reviews of Biophysics.
[44] L. Tsai,et al. Structure and Regulation of the CDK5-p25nck5a Complex , 2001 .
[45] V. Hu. The Cell Cycle , 1994, GWUMC Department of Biochemistry Annual Spring Symposia.
[46] L. Tsai,et al. Cdk5 behind the wheel: a role in trafficking and transport? , 2002, Trends in cell biology.
[47] K. Shokat,et al. Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics , 2006, Nature Structural &Molecular Biology.
[48] J. Diffley,et al. CDKs Promote DNA Replication Origin Licensing in Human Cells by Protecting Cdc6 from APC/C-Dependent Proteolysis , 2005, Cell.
[49] J. Kuriyan,et al. The Conformational Plasticity of Protein Kinases , 2002, Cell.
[50] Anindya Dutta,et al. A Bipartite Substrate Recognition Motif for Cyclin-dependent Kinases* , 2001, The Journal of Biological Chemistry.
[51] Structure of the Pho85-Pho80 CDK-cyclin complex of the phosphate-responsive signal transduction pathway. , 2007, Molecular cell.
[52] K. Akashi,et al. Mouse Development and Cell Proliferation in the Absence of D-Cyclins , 2004, Cell.
[53] B. Suter,et al. T‐loop phosphorylation stabilizes the CDK7–cyclin H–MAT1 complex in vivo and regulates its CTD kinase activity , 2001, The EMBO journal.
[54] James M. Roberts,et al. The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts , 1999, The EMBO journal.
[55] N. Pavletich. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. , 1999, Journal of molecular biology.
[56] Philip D. Jeffrey,et al. Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.
[57] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[58] Jaroslav Koča,et al. Regulatory phosphorylation of cyclin-dependent kinase 2: insights from molecular dynamics simulations , 2008, Journal of molecular modeling.
[59] T. Hunt,et al. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[60] Martin E M Noble,et al. Molecular Motions of Human Cyclin-dependent Kinase 2* , 2005, Journal of Biological Chemistry.
[61] Jiri Bartek,et al. Checking on DNA damage in S phase , 2004, Nature Reviews Molecular Cell Biology.